{"id":"W2604003845","doi":"10.1200/jco.2017.35.4_suppl.tps212","title":"CheckMate 577: A randomized, double-blind, phase 3 study of nivolumab (Nivo) or placebo in patients (Pts) with resected lower esophageal (E) or gastroesophageal junction (GEJ) cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Nivolumab; Cancer; Esophageal cancer; Gastroesophageal Junction; Oncology; Chemoradiotherapy; Placebo; Gastroenterology; Surgery; Adenocarcinoma; Immunotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009871663,0.001228705,0.00173484,0.000376619,0.0003761839,0.0009539624,0.0008138155,0.001560853,0.007674477],"category_scores_gemma":[0.0009922595,0.0005872415,0.001183797,0.0002852372,0.0007619845,0.0007069319,0.0002991126,0.002543063,0.001125915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007140848,"about_ca_system_score_gemma":0.001355809,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001163143,"about_ca_topic_score_gemma":0.003434247,"domain_scores_codex":[0.9997839,0.00009467252,0.0000108237,0.00004866259,0.00001858957,0.00004334077],"domain_scores_gemma":[0.9995366,0.0001094245,0.00009154976,0.00002855674,0.00003558381,0.000198231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9515262,0.01550824,0.0007987582,0.0009709198,0.0008640808,0.00005507509,0.00005885664,0.0004258926,0.006150161,0.0001895782,0.002492668,0.02095947],"study_design_scores_gemma":[0.9321281,0.0642082,0.001265751,0.00003352481,0.0003582151,0.00003108402,0.00001747276,0.0004728656,0.0005003951,0.0001064553,0.000864535,0.00001326995],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9781627,0.00503409,0.0009473902,0.0008090794,0.0008619466,0.007793622,0.002133178,0.0002983937,0.003959461],"genre_scores_gemma":[0.9783755,0.002823766,0.001791954,0.002260562,0.0003217547,0.007233053,0.001883881,0.00004523088,0.005264276],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007674477,"threshold_uncertainty_score":0.02567369,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1563888106235354,"score_gpt":0.5103783892273519,"score_spread":0.3539895786038165,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}